Alumni raised $1.45B in 2022 - Download Free Report Now

Myconostica (Acquired)

Real-time/PCR-based molecular diagnostic tests for life-threatening respiratory fungal infections.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Myconostica (Acquired) plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About Myconostica (Acquired)

Technology/product details

Competing Startups


Companies We Work With